| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gao Hanlin | Chief Scientific Officer | C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE | /s/ Paul Kim as Attorney-in-Fact | 02 Mar 2026 | 0001684532 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FLGT | Common Stock | Tax liability | $22,210 | -897 | -0.09% | $24.76 | 1,002,080 | 26 Feb 2026 | Direct | F1 |
| transaction | FLGT | Common Stock | Tax liability | $15,606 | -1,018 | -0.1% | $15.33 | 1,001,062 | 01 Mar 2026 | Direct | F2 |
| transaction | FLGT | Common Stock | Tax liability | $98,265 | -6,410 | -0.64% | $15.33 | 994,652 | 01 Mar 2026 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. |
| F2 | The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022. |
| F3 | The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025. |